SAPROPTERIN
sapropterin dihydrochloride 100 mg soluble tablet, 30
SAPROPTERIN (11676M)
11676M
Manner of administration:Oral
Restriction
Indication: Hyperphenylalaninaemia (HPA) due to phenylketonuria (PKU)
Treatment phase: Initial treatment - responsiveness testing
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 0 | DPMQ: $833.22 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Kuvan | |||||